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Bone formation as well as bone healing capacity is known to be impaired in the
elderly. Although bone formation is outpaced by bone resorption in aged individuals, we
hereby present a novel path that considerably impacts bone formation and architecture:
Bone formation is substantially reduced in aged individual owing to the experience
of the adaptive immunity. Thus, immune-aging in addition to chronological aging is a
potential risk factor, with an experienced immune system being recognized as more
pro-inflammatory. The role of the aging immune system on bone homeostasis and on
the bone healing cascade has so far not been considered. Within this study mice at
different age and immunological experience were analyzed toward bone properties.
Healing was assessed by introducing an osteotomy, immune cells were adoptively
transferred to disclose the difference in biological vs. chronological aging. In vitro
studies were employed to test the interaction of immune cell products (cytokines) on
cells of the musculoskeletal system. In metaphyseal bone, immune-aging affects bone
homeostasis by impacting bone formation capacity and thereby influencing mass and
microstructure of bone trabeculae leading to an overall reduced mechanical competence
as found in bone torsional testing. Furthermore, bone formation is also impacted
during bone regeneration in terms of a diminished healing capacity observed in young
animals who have an experienced human immune system. We show the impact of
an experienced immune system compared to a naïve immune system, demonstrating
the substantial differences in the healing capacity and bone homeostasis due to the
immune composition. We further showed that in vivo mechanical stimulation changed
the immune system phenotype in young mice toward a more naïve composition.
While this rescue was found to be significant in young individuals, aged mice only
showed a trend toward the reconstitution of a more naïve immune phenotype.
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Considering the immune system’s experience level in an individual, will likely allow
one to differentiate (stratify) and treat (immune-modulate) patients more effectively.
This work illustrates the relevance of including immune diagnostics when discussing
immunomodulatory therapeutic strategies for the progressively aging population of the
industrial countries.
Keywords: osteoimmunology, regeneration, bone healing, T cells, adaptive immunity, immune experience,
inflamm-aging, biological aging
INTRODUCTION
Beginning in adulthood, age-associated alterations of the
musculoskeletal system progress and eventually result in a loss of
bone mass (1, 2). With increasing life expectancy, such structural
alterations represent a growing clinical challenge: By 2050 people
over 60 years will nearly double from about 12 to 22%, to a
total of two billion (3). In parallel, trauma and associated bone
injuries increase in number and already today represent the
second most expensive medical condition (after cardio-vascular
diseases) with further increases predicted due to a more active
elderly population (4). Bone tissue is, in addition to its role
within the musculoskeletal system, the home of major parts of
the immune system. Therefore, it is not surprising that recent
research acknowledged the significant role of the immune system
in bone homeostasis (5).
The interdependency between the immune and skeletal
system has gained more and more importance in recent
orthopedic research (6–12). Bone cells require positive and
negative regulators to maintain homeostasis. Cytokines are
involved in the homeostatic and regenerative regulation
and communication between the immune system and
musculoskeletal system. Cytokines are potent mediators of
osteoclast/osteoblast function and differentiation. Classically
the cytokine regulation of bone resorption, like tumor necrosis
α (TNFα), interleukin 1 α (IL-1α), interferon γ (IFNγ), and
interleukin 17A (IL-17A), is discussed and studied but bone
forming cells are tightly regulated by cytokines as well (13–15).
Subsequent studies have identified several cytokines whose
activities inhibit bone resorption and promote bone formation,
like the IL-1 receptor antagonist (IL-1Ra), interleukin 4 (IL-4),
interleukin 10 (IL-10), interleukin 13 (IL-13), and transforming
growth factor β (TGFβ) (16). T and B cells are relevant producers
of these inflammatory cytokines but also of cytokines impacting
bone homeostasis, like osteoprotegerin (OPG) and RANK ligand
(RANKL) (17). With a better understanding of the sequential
events of the bone healing cascade, the essential role of the initial
pro-inflammatory reaction as an initiator of the healing process
has been recognized. Also, the consecutive anti-inflammatory
signaling has been acknowledged as essential in order to proceed
toward the next healing phase, the revascularization of the
fracture zone (18–20). Without reestablishing the supply, the
healing will seize. However, immune processes are not only
essential during the early healing phase. Recent research showed
that immune cells are present throughout the entire healing
process with a heightened abundance during the remodeling
phase (21) and that T cells are tightly interlinked with the
process of collagen I deposition by osteoblasts, thus defining the
structure of the newly formed bone tissue (22).
Age-related changes in the immune system have so far
not been considered in this context: Specifically, the adaptive
immune system is changing with age as a result of repetitive
pathogen/ antigen exposure (23). Due to such pathogen/antigen
exposures, there is a shift from a more naïve T/B lymphocyte
system with a huge polyclonal repertoire of antigen receptors
in young individuals toward a well-experienced (memory)
T/B lymphocyte system with only a limited antigen receptor
repertoire and thus a diminishing naïve lymphocyte pool in
aged individuals (24). Such increase in immune experience
is not directly linked to the chronological aging of an
individual and therefore described as immune-aging. An “aged”
adaptive immune system, particularly the T cells, are more
pro-inflammatory due to various reasons, including: altered
properties of memory/effector T cells in respect to tissue
infiltration, lower activation threshold and the associated
bystander activation, cytokine memory, and a diminished
control by regulatory T cells (25). In consequence, immune-
aging is accompanied with an inflamm-aging, a term recently
coined in osteoimunological research that refers to an elevated
inflammatory state in elderly (26). The heightened pro-
inflammatory capacity of an experienced adaptive immune
system is further enhanced by its effect on the innate immune
response. Pro-inflammatory cytokines such as IFNg produced
by T cells elicit a pro-inflammatory reaction through a pattern
recognition receptor mediated inflammatory response from the
innate immune system (27). Moreover, within an experienced
immune system the memory/effector T cell pool forms a self-
renewing population of tissue-resident cells which reside within
the bone marrow (28, 29). Thus, long-lived memory/effector
T cells that are fast pro-inflammatory responders to challenges
such as injuries are present in the immediate proximity of a
bone fracture and are likely to influence the healing process. We
hypothesized that immune-aging impacts bone tissue structural
properties directly, in bone homeostasis as well as in healing.
Although adaptive immunity seems to play such a central role
in homeostasis and healing, it is surprising that age-associated
changes of the immune system are so far rarely considered
(30, 31). To overcome this limitation, we present herein a
novel approach that includes animal age with and without
antigen exposure, to understand the role of adaptive immunity in
bone. Thus, the presented study aims at revealing the influence
of an experienced immune phenotype in comparison to a
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naïve immune phenotype on the tissue formation processes
in bone adaptation as well as during bone regeneration to
unravel the relevance of immune-aging and inflamm-aging
on the bone structure and thereby lay the foundation for a
more comprehensive understanding of patient treatment with
impaired bone regeneration (11).
MATERIALS AND METHODS
Animals to Study Immune-Aging
Female C57BL/6N mice were purchased from Charles River
Laboratories with an age of 8–10 weeks and were used at an age of
12, 52, and 102 weeks, respectively. Animals were imported with
a health certificate and kept under obligatory hygiene standards
that were monitored according to the FELASA standards. The
mice were kept under specific pathogen free (SPF) housing or
under non-SPF housing. Food and water was available ad libitum
and the temperature (20± 2◦C) controlled with a 12 h light/dark
circle. All experiments were carried out with ethical permission
according to the policies and principles established by the Animal
Welfare Act, the National Institutes of Health Guide for Care and
Use of Laboratory Animals, and the National Animal Welfare
Guidelines, the ARRIVE guidelines and were approved by the
local legal representative animal rights protection authorities
(Landesamt für Gesundheit und Soziales Berlin).
Mouse Osteotomy as a Model of
Fracture Healing
Bone regeneration was studied by introducing an osteotomy
on the left femur. Therefore, the mice were anesthetized with
a mixture of isoflurane (Forene) and oxygen (Induction with
2% Isoflurane and maintenance with 1.5%). First line analgesia
was done with Bubrenorphine pre surgery, antibiotics with
clindamycine and eye ointment to protect the eyes. Post-surgery,
tramadol (Tramal) was added to the drinking water for 3 days.
The surgical area was shaved and disinfected, and all surgical
procedures were performed on a heating pad (37◦C). The
osteotomy was performed as previously published (32). Shortly,
a longitudinal, lateral skin incision and dissection of the fasciae
allowed to expose the femur. The Musculus vastus lateralis and
Musculus biceps femoriswere dislodged by blunt preparation with
protection of the sciatic nerve. Thereafter, serial drilling for pin
placement (diameter: 0.45mm) through the connectors of the
external fixator (MouseExFix, RISystem, Davos, Switzerland) was
performed, resulting in a fixation of the external fixator construct
strictly parallel to the femur. Following rigid fixation, a 0.70mm
osteotomy was performed between the medial pins using a Gigli
wire saw (RISystem, Davos, Switzerland). After skin closure, mice
were returned to their cages and kept under warming lamps for
the period of immediate anesthesia recovery.
Bone Tissue Sample Preparation and
Flow Cytometry
Animals were intraperitoneally injected with a mixture of
medetomidine and ketamine to induce a deep anesthesia,
thereafter euthanized by cervical dislocation. Blood, spleen, and
the hind limbs were removed and stored for transportation in
ice cold phosphate-buffered saline (PBS). For flow cytometry the
spleen was dissected andmashed through a 70µmmesh to isolate
the splenocytes. Erythrocytes were removed by incubation with
the RBC Lysis Buffer (BioLegend, San Diego, CA USA). The
bone marrow was isolated by cutting open both end of femora
or tibia and flushing the bone marrow out of the cavity with a
24G needle and PBS. The single cell suspension was incubated
with a fixable live/dead stain (LIVE/DEADTM Fixable Blue Dead
Cell Stain Kit, for UV excitation (InvitrogenTM, Waltham, MA
USA) and subsequently washed with PBS, 0.5% BSA, and 0.1%
NaN3. Before incubation with the antibodies, the fc receptors
were blocked with the TruStain fcXTM (anti-mouse CD16/32)
Antibody (BioLegend, San Diego, CA USA). Surface epitopes
were stained with fluorochrome coupled antibodies for 20min
on ice. For intracellular staining the surface stained cells were
incubated with the eBioscienceTM Foxp3/Transcription Factor
Staining Buffer Set (InvitrogenTM, Waltham,MAUSA) according
to the manufacture’s protocol. Intracellular epitopes were stained
for 30min at room temperature. Stained cells were analyzed on a
BD LSRFortessaTM cell analyzer (BD Biosciences, Franklin Lakes,
NJ USA). For a list of used antibodies and conjugates please refer
to the Supplementary Table 1.
Biomechanical Analyses of Femur
Tissue Competence
The torsional stiffness, the maximum torque, its corresponding
angle and workload were assessed in a torsional load to failure
experiment. Following harvesting, the femora were excised
and prepared by removing all adjacent muscles and tendons.
Subsequently both epiphyses of the femora were embedded with
methylmethacrylate (Technovit 3040, Heraeus Kulzer, Hanau,
Germany) in custom made molds. Eventually, bones were
mounted into a material testing device (Bose ElectroForce LM1,
TA Instruments, Eden Prairie, MN USA) and tested by first
applying an axially preloaded of 0.3N which remained constant
during the following torsional load to failure at a rate of 0.54◦/s.
Axial displacement, load, torque, and rotationwere all acquired at
a 100Hz sample rate. All parameters were calculated by a routine
written in MATLAB (The Mathworks, Inc. Natick, MA USA).
3D Structural Analysis of Cortical and
Trabecular Bone Using microCT
Technology
Following harvesting, structural intact bones were cleaned of
excess soft tissue and fixed in buffered formalin and directly
loaded on a custom made sample holder and scanned at
a nominal resolution of 8 and 1µm, respectively, with a
Bruker SkyScan 1172 high-resolution microCT (Bruker, Kontich,
Belgium). A 0.5mm aluminum filter was employed and an x-
ray tube voltage of 70 kV. Camera pixel binning of 2 x 2 was
applied and the scan orbit was 180 degrees for 8µm and 360
degrees for 1µm, respectively, with a rotation step of 0.2 degree.
Reconstruction was carried out with a modified Feldkamp
algorithm using the SkyScan NRecon software accelerated by
GPU. Gaussian smoothing, ring artifact reduction, misalignment
compensation, and beam hardening correction were applied.
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The cortical bone was analyzed 4mm cranial from the knee
growth plate and a volume of interest (VOI) of the height of
1.6mm was extracted. The VOI for the trabecular bone was set
0.4mm above the growth plate and had a height of 5.2mm, as
this VOI included also the most cranial trabecular structures. The
cortical bone region was binarised with a global threshold and for
the trabecular bone an adaptive thresholding was applied based
on localized analysis of density, to minimize partial volume effect
and thickness biasing.
Osteotomized femora were mechanically fixed within a
serological pipette (to support integrity of the fractured bone)
and the external fixator was removed. Those bones were handled
likewise as structural intact bones. Global thresholds were
selected by the Otsu algorithm. The same global threshold values
were applied to all measured bone samples corresponding to
bone mineral density (BMD) value of 590 mg/cm3 calcium
hydroxyapatite (CaHA), calibrated by reference phantoms
(Bruker-microCT, Kontich, Belgium) containing 0.25 and 0.75
g/cm3 CaHA evenly mixed in epoxy resin rods which were
of similar diameter to the scanned bones to minimize beam
hardening error.
In vitro Assays to Analyze the
Osteogenic Differentiation
Murine Cell Culture
Splenocytes and bone marrow cells were isolated from spleen
and bone tissue from mice with different ages. The spleen was
dissected and mashed through a 70µm mesh to isolate the
splenocytes. Erythrocytes were removed by incubation with the
ACK Lysing Buffer (Gibco, Waltham, MA USA). The bone
marrow was isolated by cutting open both end of femora or
tibia and flushing the bone marrow out of the cavity with a
24G needle and PBS, after filtration through a 40µm mesh
strain, red blood cells were removed with the ACK Lysing Buffer
(Gibco, Waltham, MA USA). The splenocytes were activated at
a density of 2 × 106 cells/ml with 10 mg/ml plate bound anti-
CD3 antibody and soluble 2 mg/ml anti-CD28 (BioLegend, San
Diego, CAUSA) in RPMI-1640 medium supplemented with 10%
heat-inactivated FBS. After 48 h the conditioned medium was
collected, pooled, filtered through a 0.22µm hydrophobic filter
(Sartorius) and stored at −80◦C. Murine mesenchymal stromal
cells were obtained via outgrowth culture from bone marrow
cells. The isolated single cells from bone marrow was plated
in 25 cm2 cell culture plates with DMEM low glucose medium
(Biochrom, Berlin, Germany) supplemented with 10% FBS
(Biochrom, Berlin, Germany), 1% GlutaMAX (Gibco, Waltham,
MA USA), and 1% penicillin/streptomycin (Biochrom, Berlin,
Germany). After reaching confluency, the cells were detached
with TrypLE Express Enzyme (Gibco, Waltham, MA USA) and
cultured in passage 1 again in a 25 cm2 culture flask. By passage 2
the cells were transferred gradually with higher passage number
in 75, 150, and 300 cm2 cell culture flasks. Murine mesenchymal
stromal cells (mMSC) were used between passage 5 and 6 for the
experiments. Osteogenic differentiation of mMSC was achieved
by the supplementation with 100 nMDexamethasone, 0.05mM l-
ascorbic acid 2-phosphate, and 10mM β-Glycerolphosphate (33).
Conditioned medium was added at a dilution of one to three
(1:3). Medium was exchanged every 3–4 days. After 14 days the
experiment was stopped and the mineralized extracellular matrix
was stained with Alizarin Red S (Sigma-Aldrich, St. Louis, MO
USA) and quantification was achieved by resolving the stain with
cetylpyridiniumchlorid (Sigma-Aldrich, St. Louis, MO USA).
Optical density (OD) wasmeasured with amultimodemicroplate
reader (Tecan Infinite, Männedorf, Switzerland).
Human Cell Culture
Human mesenchymal stromal cells (hMSC) were isolated from
bone marrow of patients undergoing total hip replacement
(provided by the Center for Musculoskeletal Surgery, Charité
- Universitätsmedizin Berlin and distributed by the “Cell and
Tissue Harvesting” Core Facility of the BCRT). All protocols were
approved by the Charité - Universitätsmedizin Ethics Committee
and performed according to the Helsinki Declaration. Human
MSC were cultivated with DMEM low glucose medium
(Biochrom, Berlin, Germany) supplemented with 10% FBS
(Biochrom, Berlin, Germany), 1% GlutaMAX (Gibco, Waltham,
MA USA), and 1% penicillin/streptomycin (Biochrom, Berlin,
Germany). After three passaging steps, hMSC were characterized
by differentiation assays (osteogenic, adipogenic, chondrogenic).
Only hMSC that were capable of differentiation in all three
lineages were used in the experiment within passage 4–8. Human
peripheral blood mononuclear cells (hPBMC) were isolated from
buffy coats (provided with ethical approval by DRK, Berlin,
Germany) via density gradient centrifugation on Histopaque-
1077 (Sigma-Aldrich, St. Louis, MO USA). The buffy coats were
separated from blood donor volunteers by the Deutsches Rotes
Kreuz (DRK) and fulfilled the criteria of age >30 years old and
cytomegalovirus (CMV) positive. Isolation of naïve T cells was
achieved with the Naïve T Cell Isolation Kit (Miltenyi Biotec,
Bergisch Gladbach, Germany) and CD8+ T cells were isolated
via CD8a microbeads (Miltenyi Biotec, Bergisch Gladbach,
Germany). The hPBMC were activated at a density of 2 × 106
cells/ml with 10 mg/ml plate bound anti-CD3 antibody and
soluble 2 mg/ml anti-CD28 (BioLegend, San Diego, CA USA)
in RPMI-1640 medium supplemented with 10% heat-inactivated
FBS. After 48 h the conditioned medium was collected, pooled,
filtered through a 0.22µm hydrophobic filter (Sartorius) and
stored at −80◦C until further use. Osteogenic differentiation of
hMSC, under the influence of conditionedmedium from hPBMC
was developed likewise to murine MSC.
Enzyme-Linked Immunosorbent
Assay (ELISA)
Conditioned medium from activated murine splenocytes were
harvested as described and processed for enzyme-linked
immunosorbent assay (ELISA). ELISA for TNFα (Mouse
TNFalpha ELISA ReadySet-Go! 10x #88-7324-86, eBioscience),
IFNγ (Mouse IFN gamma ELISA Ready-SET-Go! 10x #88-7314-
86, eBioscience), and IL-10 (Mouse IL-10 ELISA Ready-SET-
Go! #88-7105-86, eBioscience) was performed according to the
manufacturer’s instructions in triplicates and optical density
was measured with a microplate reader Tecan Infinite (Tecan,
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Männedorf, Switzerland). A standard curve was generated with
a four parametric logistic curve fit.
Conditioned medium from activated human PBMC were
harvested as described and processed for quantitative cytokine
detection via ELISA. ELISA for human TNFα (Human TNF
alpha Uncoated ELISA, 88-7346, Invitrogen) and human IFNγ
(Human IFN gamma Uncoated ELISA, 88-7316, Invitrogen)
was performed according to the manufacturer’s instructions in
triplicates and optical density was measured with a microplate
reader Tecan Infinite (Tecan, Männedorf, Switzerland). A
standard curve was generated with a four parametric logistic
curve fit.
Mechano-Therapeutics: in vivo Hind Limb
Loading to Analyze Bone Adaptation and
Homeostasis
The left tibiae of 10 week (young) and 52 week (aged) old
C57Bl/6J mice (N = 6/age) underwent in vivo cyclic compressive
loading, while the right tibia was not loaded and served as an
internal control. The flexed knee and the ankle of the mice
were placed in our loading device (Bose ElectroForce LM1,
TA Instruments, Eden Prairie, MN USA) and axial dynamic
compressive loading was applied 5 days/week for 2 weeks while
the mice were anesthetized with isoflurane (2.5%). Refer toWillie
et al. (34) for further information. Shortly, the loading protocol
consisted of 216 cycles applied at 4Hz, which is the mean
mouse locomotory stride frequency (35) delivering a maximum
force of −7N for the 10 and −9N for the 52 week old mice,
engendering 900 µε at the periosteal surface in the tibia mid-
diaphysis determined by prior in vivo strain gauging studies
(36). This strain level equates to about two to three times the
strains engendered on the medial tibia when mouse ambulates
(37, 38). Mice were sacrificed on day 15, 3 days after the last
loading session.
Humanized PBMC Mouse Model to Assess
the Osteo-Immune Crosstalk
The humanized peripheral blood mononuclear cell (hPBMC)
mouse model is described elsewhere (39–41). Shortly, human
PBMC were isolated from venous blood from volunteers
via density gradient centrifugation with Histopaque-1077
(Sigma-Aldrich, St. Louis, MO USA). Immune phenotype was
characterized with flow cytometry. Cells were incubated with a
fixable live/dead stain (LIVE/DEADTM Fixable Blue Dead Cell
Stain Kit, for UV excitation, InvitrogenTM, Waltham, MA USA)
and subsequently washed with phosphate-buffered saline (PBS),
0.5%BSA, and 0.1%NaN3. Before incubationwith the antibodies,
the fc receptors were blocked with the Fc Receptor Blocking
Solution (Human TruStain fcXTM, BioLegend, San Diego, CA
USA). Surface epitopes were stained with fluorochrome coupled
antibodies for 20min. Stained cells were analyzed on a BD
LSRFortessaTM cell analyzer (BD Biosciences, Franklin Lakes, NJ
USA). For a list of used antibodies and conjugates please refer
to the Supplementary Table 2. Experience level for stratification
was achieved via the CD8+ TEMRA level: 36% [the level was
set corresponding to Reinke et al. (42)] and higher were
classified as experienced and below 20% as naïve donors.
Donor immune phenotype characterization can be found in
the Supplementary Table 3. Ten million freshly isolated and
characterized hPBMCs were transferred at a density of 5 ×
106 cells/ml PBS via tail vein injection 1 day before surgery.
After 3 or 21 days the organs were harvested and analyzed.
An osteotomy was introduced as described in the preceding
paragraph. For the analysis 21 days after surgery the callus region
of the osteotomized femur was defined as a region of 1.4mm
(double the size of the fracture gap to include the complete callus)
around the middle of the fracture gap. The cell transfer has been
confirmed by blood sampling and consecutive flow cytometry
analysis at day 3 and day 21 after osteotomy surgery.
Statistics
Statistical analysis was carried out with SPSS V.22 and GraphPad
Prism V.7 software. All values including animal data are
expressed as boxplot distribution giving interquartile ranges,
a median, and whiskers representing min and max. All data
including in vitro studies are expressed with mean ± SD.
For animal experiments Mann-Whitney U was used as an
unpaired, non-parametric test to compare ranks (no normal
distribution of the data), for in vitro studies an unpaired t-test
with Welch’s correction was employed. Two-tailed and exact p-
value are calculated with a confidence level of 95%. P < 0.05 was
considered as statistically significant and marked with an asterisk
in all graphics. ROUT test was used to exclude outliers (Q= 1%).
RESULTS
Fracture Healing Deteriorates With Age
While it is frequently discussed that bone healing is impaired
in the aged population, it is so far not well-understood how
healing is impaired with increased chronological age apart
from the age-associated decline in bone mass and quality.
It is also recognized that bone fractures tend to heal more
effectively in young patients compared to those in elderly
(Figure 1A). To better understand how bone healing is altered
with chronological age, a clinically relevant mouse osteotomy
model was employed and bone healing was compared in young,
3 month old and elderly, 24 month old mice. Both groups of
mice received a 0.7mm osteotomy in the left femur which was
stabilized by a unilateral external fixator (MouseExFix, RISystem,
Davos, Switzerland). To quantify bone healing outcome, mice
were analyzed at 21 days post-osteotomy using microcomputed
tomography (microCT). 3D structural data analysis revealed a
more mature callus in young mice compared to aged mice. The
newly formed bone (BV) volume slightly decreased and the total
callus volume (TV) showed a trend to be increased, whereas
the ratio of bone to total callus volume decreased significantly
from 48.5(±5.2) to 38.6(±1.0)%.The number of newly formed
trabecular structures (Trabecular number, Tb.N) within the
callus decreased significantly from 4.7(±0.5) to 3.6(±0.6)/mm in
aged animals (Figures 1B,C). Thus, the comparison of young vs.
elderly mice clearly demonstrated a diminished healing capacity
of bone and matches the casual observations made in elderly
patients suffering delays in bone healing.
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FIGURE 1 | Fracture healing among young and old subjects: (A left) X-ray images from a young patient with adequate callus formation after 6 months and (A right)
from an old patient with no signs of healing after 3 months, leading to delayed fracture healing and revision surgery. This x-ray images are representative images from
the clinical routine and depict the need to understand the altered processes within the elderly population. (B) 3D rendered x-ray images from 3 to 24 month old mice,
respectively, at 21 days post-surgery. Bone healing was delayed in 24 month old compared to the 3 month old mice. (C) microCT analysis from the osteotomy gap 21
days post-surgery. Bone volume in total volume (BV/TV) and trabecular number (Tb.N) were diminished in 24 month old fracture callus. TV and BV were not
significantly affected by age, but the ratio of newly formed bone in the callus volume was significantly lowered. N = 6 animals in the 3 months old group and N = 5 in
the 24 months old group, boxplot data distribution with median, Mann-Whitney U-test, *p < 0.05.
Antigen Exposure Over Time Alters the
Immune Cell Composition
Standard preclinical models use in the majority of cases mice
kept under specific pathogen free (SPF) housing conditions—
minimizing the exposure to antigens. SPF housing significantly
demagnifies the intra-individual variabilities through abolishing
the pathogen/antigen exposure. In order to understand the
immune-aging process and the development of an immune
memory with effector and effector memory cells that are apt
to protect the organism from recurrent pathogen exposure,
mice were exposed to non-SPF housing conditions. Comparing
mice held under SPF conditions with mice that were housed
in non-SPF conditions revealed changes within the immune
cell composition that mirror the immune-aging that commonly
occurs to people while they grow old. These two groups
allow one to distinguish between the changes in bone that
occur by chronological aging and those changes that are due
to the immunological aging. For quantification, the immune
composition was characterized by flow cytometry analysis of the
spleen from 3, 12, and 24 month old mice, respectively. Antigen
exposure primarily influenced the memory compartment of the
adaptive immunity over age/time. In both groups, the adaptive
immune cell compartment, consisting primary of CD4+ and
CD8+ T cells, acquired a more experienced memory phenotype
while aging. The naïve cell pool of CD8+ cytotoxic T cells in the
SPF mice diminished over time from 90.7(±1.3) to 77.8(±8.3)%
within 2 years. However, a more drastic change was observed in
the exposed mice: Under non-SPF conditions the memory pool
increased to 95.5(±2.4)% of CD8+ T cells whereas the naïve pool
was almost completely exhausted with a remnant of 3.0(±1.8)%.
Only under non-SPF conditions such nearly complete exhausting
of the naïve T cell pool in aged mice could be observed. Similar
phenotypical changes could be observed in the CD4+ T helper
cell pool (Figure 2A).
The memory and effector pool (CD44+) can be distinguished
by the CD62L marker into central memory (TCM) and effector
memory (TEM) T cells. Both compartments of CD8+ T cells
increase with age, but only under non-SPF conditions the inter-
individual variance of comparentalization could be seen (see
Figure 2B). In the CD4+ T cell pool a similar picture could be
observed compared to CD8+ T cells with less variance between
individual animals. Interestingly, the CD4+ T central memory
pool was constant among age and housing condition groups
(Figure 2B). An increase in memory and effector function of the
adaptive immune system was revealed with age and correlated
with the housing conditions, which defined the antigen exposure
and thus the development of an immune memory.
The classification in T effector/memory (TEM), T central
memory (TCM) and T naïve cells in the CD8+ T cell pool
describes the compartmentalization, but lacks a description
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FIGURE 2 | Adaptive immunity changes level of experience among housing conditions (SPF vs. non-SPF) and aging. (A) Naïve level of CD4+ and CD8+ T cells
diminished and the memory level increased with aging. Exposing the animals to antigens boosts the memory formation significantly. (B) Classification of T cells into
central memory (TCM) and effector memory (TEM) revealed a different picture for CD4+ and CD8+ T cells: CD8+ T cells increased both compartments under
non-SPF conditions, whereas the CD4+ central memory T cells were constant among ages and housing conditions. Keeping mice under SPF conditions oppressed
the effect of memory formation. (C) CD8+ memory T cells differ in the recall efficiency after antigen encounter. Strong responder CD8+ memory T cells were not
affected by non-SPF housing, whereas intermediate responder could only be found under non-SPF conditions (intermediate responder are proven to show fast
proliferation and vast cytokine production). The low responder fraction diminished further under non-SPF conditions compared to SPF housing. N = 6 animals per age
group and housing conditions, (A,B) shows median with interquartile range, (C) shows boxplot distribution with median, Mann Whitney U-test, *p < 0.05.
of the activation phenotype. Memory CD8+ T cells differ in
their capacities to realize a recall response. To quantify the
activation potential of immune cells, the spleen of mice under
SPF or non-SPF conditions was analyzed in the different age
groups. The recall efficiency was classified by surface markers
CXCR3 (CD183), CD27, and CD43. CD8+CD44+ memory T
cells can be divided in 3 groups of low, intermediate and strong
responders. An increase in CXCR3 on the cell surface correlates
with an increased proliferative capacity and an increased IL-2
production. Whereas, the low responder characterized by low
CXCR3 and CD43 marker show low proliferative capacity and
reduced IL-2 production but an increase Granzyme B secretion.
Intermediate responder upregulate the CD43 protein on the cell
surface and are characterized by a very pronounced proliferation
and an elevated secretion of cytokines. The low responder
group of CD8+ memory T cells decreased with age and the
strong responder increased, almost doubling their population
quantity. The increase of strong responder within the memory
CD8+ T cells amplifies the earlier finding of an accumulation
of memory cells over time. Intermediate responders were
almost exclusively found in higher numbers under non-SPF
conditions. Under antigen exposure the low responder immune
cells decreased over time being replaced by intermediate
and strong responder indicating a pronounced inflammatory
reaction (Figure 2C). Thus, the activation phenotype revealed
a higher proliferative and secretory phenotype in mice kept
under non-SPF conditions undergoing an immune-aging
that consecutively lead to an amplified response capacity
upon recall.
Immune-aging (antigen exposure) became further apparent
by an in-depth immune phenotyping of these two mice
groups kept under different (SPF vs. non-SPF) housing
conditions. Strikingly, if mice were kept outside of the SPF
housing, a shift occurred from lymphoid toward myeloid
immune cells and a shift of the ratio of B and T cells toward
T cells (Figure 3A). T cells themselves underwent a shift
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FIGURE 3 | In-depth immune phenotyping showed, that keeping mice under non-SPF conditions significantly changes the immune phenotype with age. (A) A shift
from lymphoid toward myeloid immune cells could be seen in a lowered B and T cell fraction in the spleen, accompanied by a change of the ratio of B and T cells
toward T cells. (B) Dendritic cells increased under non-SPF conditions and a shift toward conventional DCs (cDC) occurred. (C) Natural killer cells (NK cells) and
especially Natural killer T cells (NKT) increased with higher age. (D) Under non-SPF conditions a shift from CD8+ T cells toward CD4+ T cells occurred, being stable
thereafter throughout aging. (E) CD8+ effector memory T cells can further be divided into memory (Tem), memory precursor effector cells (MPEC) and short-lived
effector cells (SLEC). The diversity of effector cells increased with age. (F) CD4+ T regulatory cells (Treg) increased with age. (G) CD8+ T regulatory cells (Treg) are a
rare cell population, but could be found in relevant amounts in 24 months old mice. N = 6 animals per group, boxplot distribution with median, Mann-Whitney U-test,
*p < 0.05.
of the CD4/CD8 ratio toward a more pronounced CD4+
compartment: CD4+ T cells represented ∼70–80% of all CD3+
cells under non-SPF conditions, whereas under SPF conditions
the CD4+ T cell pool represented only around 60% of all
CD3+ cells (Figure 3D). The CD8+ T effector memory pool
(CD8+CD44+CD62L-) can further be divided in T effector
memory, memory precursor (MPEC), and short-lived effector
cells (SLEC) via the markers CD127 and KLRG1. In all three
compartments, the inter-individual variance increased with
age under non-SPF housing (Figure 3E). Within the CD4+ T
cell pool the T regulatory cells (Tregs) are of great interest and
this immune cell compartment underwent significant changes
with age. With 3 month of age 10.2(±1.7)% of CD4+ T cells
were Tregs (FoxP3+CD25high), which further increased to
17.1(±3.1)% at 12 and to 23.8(±4.4)% at 24 months (Figure 3F).
While the proportion of CD8+ Tregs seemed to be stable
in the two younger groups, at 24 months the level of CD8+
Tregs increased (Figure 3G). As professional antigen presenting
cells (APCs) dendritic cells (DCs) are unrivaled in their
capability to activate T cells. We found that specifically the
dendritic cells underwent a shift from splenic CD8+ and CD4+
DCs toward conventional splenic DCs in non-SPF housing
conditions (Figure 3B). Regarding the compartments of
NK and NKT cells, both cell subpopulations showed a
significant increase in the 24-months-aged mice under non-SPF
conditions (Figure 3C).
In summary, antigen exposure appears to be very crucial
for the development of a diversified immune system, especially
impacting the development of a specific memory functionality of
the immune system.
To distinguish between changes within the bone that
occur during chronological aging and those that are caused
by the immune-aging, bones of mice with a more naïve
immune composition (aged within an SPF surrounding)
were compared, using microCT and biomechanical
testing, to bones of mice aged with the possibility to
develop an immune memory (immune-aging within
non-SPF housing).
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The Immune Signature Changes the
Mechanical Competence of Bone
Biomechanical testing of the femora was conducted with
a mechanical testing machine (Bose ElectroForce LM1, TA
Instruments, Eden Prairie, MN USA), and loaded to failure in
torsion to characterize the mechanical competence of bone under
the influence of differently experienced immune phenotypes and
in different age groups. Three groups of six animals each were
analyzed: 3 month old were considered as young mice without
an experienced immune system. Two groups with 12 month
old middle age mice were set as aged groups. One group of
aged mice was housed under SPF and one group under non-
SPF conditions to gain an experience level in the adaptive
immunity. Thus, the two aged groups only differed in their
immune cell composition and thus any changes of themechanical
competence are due to the difference in the immune phenotype.
The stiffness of the femora increased by age from initial 5.4(±0.5)
Nmm/deg at 3 months to 7.0(±0.3) Nmm/deg at 12months. This
change was accredited to the chronological aging. The excessive
increase to 8.4(±0.9) Nmm/deg seen in animals in non-SPF
housing had to be attributed to the more experienced immune
system. Torque at the yield point increased with age and was
significant higher under non-SPF conditions. The failure torque
increased with chronological age, but also showed a further
increase with an experienced immune phenotype (however
lacking statistical significance): Maximal torque at failure at 3
months of age 20.4(±2.6) Nmm increased to 28.3(±5.3) Nmm
at 12 months SPF and 31.2(±6.1) Nmm at 12 months non-
SPF, respectively. The post-yield displacement analysis revealed
a ductile fracture manner in 3 month old mice and changed to a
brittle fracture manner with age and a significant change under
non-SPF housing (Figure 4). An experienced, immune-aged
system, characterized by a higher pro-inflammatory environment
resulted in changed biomechanical competences of the bone.
To further investigate the underlying structural causes of
this difference in mechanical competence, bone structure was
analyzed using microCT analysis.
The Immune Signature Impacts the
Bone Structures
MicroCT analysis was performed on femora of 3 months young
mice and two 12 months old groups with one kept under
SPF housing (called 12 months SPF) and one kept in non-
SPF housing (called 12 months non-SPF) to allow for analyses
of chronological aging vs. immune-aging with an increased
immunological memory. Both of the old groups showed an
aged bone phenotype, additional changes of the bone structure
were found within the old mice with an experienced immune
phenotype (non-SPF).
Cortical Bone Structure
Total area (Tt.Ar) and bone area (Ct.Ar) increased with age,
however both outcome measures were significantly increased
in the 12 months non-SPF group compared to the 12 months
SPF group. The medullary area (Ma.Ar) did not significantly
differ between the groups, leaving the bone marrow canal
mostly unaffected. The ratio of bone area inside the tissue area
FIGURE 4 | Torsional testing of mouse femora with different immune
phenotype. Keeping mouse under non-SPF conditions increased the torsional
stiffness compared to 12 months old SPF mice. Yield torque and maximal
torque increased by age and was further affected by non-SPF housing. The
post-yield displacement (PYD) revelaed a more brittle fracture manner at 12
months under non-SPF compared to 12 months under SPF housing, the 3
month old bone fractured in a more ductile manner. N = 6 per group, boxplot
distribution with median, Mann-Whitney U-test, *p < 0.05.
(Ct.Ar/Tt.Ar) was also only different in the aged experienced
mouse group, showing an increased ratio of Ct.Ar/Tt.Ar.
Strikingly, the total mineral density (TMD) of the cortical bone
increased only by age and was not altered by the immune
experience (Figure 5A). One micrometer resolution scans
revealed a periosteal thickness increase with age, specifically
on the lateral aspect of the cortex (Figure 5B). While in
chronological aging, the cortical thickness increased from initial
149(±7) µm at 3 months to 165(±6) µm at 12 months, it
increased under the influence of an experienced immune system
to 192(±11) µm. Interestingly, this effect was very pronounced
on the lateral cortex and demonstrates the general impact of
altered immune experience on bone structures such as cortical
periosteal perimeter and cortical area.
To judge the mechanical competence of the structure, the
mean polar moment of inertia (MMI-polar) was calculated
to quantify the bone’s capability to resist against rotational
loads. The MMI-polar increased with age, reflecting the bone
phenotype and age associated adaptation of its mechanical
competence like the stiffness of long bones. Surprisingly, this
effect of age associated changes in polar moment of inertia were
further pronounced in a more experienced immune system.
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FIGURE 5 | MicroCT analysis of femoral cortical bone. (A) Mean total area (Tt.Ar) and cortical area (Ct.Ar) increased under non-SPF conditions compared to SPF
conditions. The medullary area (Ma.Ar) and endocortical perimeter (Ec.Pm) are slightly increased, but the periosteal perimeter (Ps.Pm) and cortical thickness (Ct.Th)
are significantly increased, demonstrating growth in lateral directions. The ratio of cortical to total area (Ct.Ar/Tt.Ar) was significantly increased in 12 months old mice
under non-SPF conditions. Therefore, polar moments of inertia (MMI-polar) were significantly higher under non-SPF conditions. The eccentricity (Ecc) was constant
throughout all groups, indicating a constant shape of the cortical femoral bone. Most strikingly the total mineral density (TMD) of the cortical bone was not affected by
the housing condition. (B top) A density map of the cortical bone comparing a 3 months old mouse with a biologically aged 12 months old mouse. (B bottom)
Representative images of the cortical bone of a 3 months old mouse compared to 12 months old mice either under SPF or non-SPF conditions. N = 6 per group,
boxplot distribution with median, Mann-Whitney U-test, *p < 0.05.
Eccentricity (Ecc) is a shape analysis used to define structural
deformation of the scanned bones. This parameter was the
same for all three analyzed groups indicating that the shape of
the cortical bone did not differ among all three groups. The
overall mean eccentricity of 0.686(±0.022) indicates a generally
elongated, more elliptical object but did not differ neither in
chronological nor immunological aged groups (Figure 5A).
Trabecular Bone Structure
Bone volume (BV/TV) and trabecular number (Tb.N) decreased
with age, independent of the immune experience. However, the
trabecular thickness (Tb.Th) was highly effected by the immune
cell composition. The trabeculae of 3 month old mice showed a
mean thickness of 38(±1) µm and 12 month SPF mice showed
an increased thickness to 47(±3) µm, while 12 month non-
SPF mice had an even further increased thickness to 53(±5)
µm. Trabecular separation indicates the distance between bony
structures and revealed that with age the distance increased
reflecting the loss of the number of structures, but the two aged
groups did not differ. The bone mineral density (BMD) is not
affected and the BMD decreases only by age and not by the
immune status (Figures 6A,B).
The femur length only differed by age, but not with exposure
to non-SPF housing conditions. Three months old mice showed
a femur length of 14.54mm± 0.07, the aged 12 months old mice
under SPF conditions showed a femur length of 16.59mm± 0.13
comparable to the non-SPF housed mice with 16.86mm ± 0.27.
The weight increased from roughly 22 g at 3 months of age to 27 g
in both of the 12 months old group of mice.
In summary, the results show clearly an impact of the immune
experience on bone structures but not on bone mineral density.
This is a new and so far not reported link between the immune
system and the bone structural properties, apparently impacting
mechanical competence of bone. The immune experience in
12 month old mice had a significant impact on cortical and
trabecular bone microstructure. An experienced immune system
led to increases in thickness of the trabecular and cortical bone.
So far, our data illustrate the relevant impact of immune
experience on the bone structure. To determine the underlying
mechanism, the influence of the immune cell signaling on the
osteogenic differentiation of mesenchymal stromal cells had
to be investigated. To simulate the immune reaction of an
inexperienced vs. an experienced immune system, conditioned
medium of activated cells from respective donors was used in
osteogenic differentiation assays.
Immune Cells Influence Differentiation and
Proliferation of Stromal Cells
To understand why cortical and trabecular microstructure
was affected by the adaptive immunity, the interdependency
of the immune cells and the bone forming osteoblasts was
investigated using mesenchymal stromal cells as an in vitro
model. To differentiate between the influence of chronological
age and experience of the immune system, immune cells from
3 to 12 month old mice were isolated from the spleen, while
mesenchymal stromal cells were isolated from bone marrow.
Aged mesenchymal stromal cells showed an alleviated ability
to differentiate toward the osteogenic lineage: Intensity of the
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FIGURE 6 | MicroCT analysis of femoral trabecular bone. (A) The ratio of bone volume in total volume (BV/TV) and the number of trabecular structures (Tb.N) were
both lowered with age, the separation (Tb.Sp) thereafter increased with age. The age dependent loss of trabecular bone was not affected by housing conditions, but
the diversity significantly increased under non-SPF conditions. Most strikingly, the trabecular thickness (Tb.Th) not only increased by age but further increased under
non-SPF conditions. The connectivity (Conn.D) was not affected by the housing conditions. As seen in the cortical bone analysis the mineral density (BMD) was only
affected by age but not by housing conditions. (B top) Representative 3D rendered images of trabecular bone comparing a 3 months old mouse with a biologically
aged 12 months old mouse. (B bottom) Representative images of 3D rendered images of trabecular bone of a 3 months old mouse compared to 12 months old mice
either under SPF or non-SPF conditions. N = 6 per group, these are the same samples analyzed for the cortical bone parameters (Figure 5), boxplot distribution with
median, Mann-Whitney U-test, *p < 0.05.
Alizarin red S staining of the extracellular matrix decreased with
age (Figure 7). To represent an immunologically inexperienced
immune setting, splenocytes of 3 month old, young mice
were stimulated and conditioned medium was harvested. The
experienced immune composition was simulated by gaining
conditioned medium from splenocytes of 12 month old,
immunologically experienced mice. The respective conditioned
medium was then added to young or old mesenchymal
stromal cells which underwent osteogenic differentiation. As a
control conditioned medium from non-activated splenocytes,
from both ages was used. Conditioned medium (CM) from
activated immune cells decreased the osteogenic differentiation
of mMSCs in both age groups compared to non-activated CM
and osteogenic medium control (OM). The conditioned medium
was either added to 3 months old mMSCs or to the less
competent 12 months old mMSCs. In both mMSC groups the
conditioned medium gained from the experienced immune cells
decreased the osteogenic differentiation significantly (Figure 7).
Analyses of the conditioned medium with enzyme-linked
immunosorbent assay (ELISA) revealed an increase in pro-
inflammatory cytokines like interferon γ (IFNγ) and tumor
necrosis factor α (TNFα) (Figure 7C). Amazingly, interleukin
10 (IL-10), known to have anti-inflammatory properties,
was also increased (Figure 7C). These results confirmed
that an experienced immune system shows an increased
pro-inflammatory capacity—that is negatively affecting the
osteogenic potential of MSCs. Hence, osteogenic differentiation
of mesenchymal stromal cells is damped under the influence of
an aged immune system.
The influence of the immune composition on osteogenic
processes further confirm that bone formation, mechanical
competence, and structure are dependent on the age/experience
of the immune cells. But how would a perturbation alter the
interplay of immune and bone system, such as in a homeostatic
setting? During bone homeostasis, a key modulator of tissue
formation and resorption is the mechanical loading experienced
by the bone. Bone adapts to the experienced mechanical loads
(43). Is such a mechanically induced bone formation process
also affected by the experience of the immune system? A well-
established limb-loading model was used in young and aged
animals and the changes in the immune cell composition in the
bone marrow of loaded bones were monitored.
In vivo Perturbation: Mechanical Loading
as a Rescue for Immune Experience?
The bone’s capability to adapt itsmass and architecture to changes
in the mechanical loading environment is a remarkable function.
While mechanical loading enhances bone mass in young mice,
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FIGURE 7 | Osteogenic differentiation after 14 days under the influence of
conditioned medium from immune cells. (A) 3 months old mesenchymal
stromal cells (MSC) were compared to 12 months old MSC. The 12 months
old MSC showed a reduced osteogenic differentiation potential compared to 3
months old MSC. Adding conditioned medium from immune cells
(conditioning for 48 h) that were not activated did not affect the osteogenic
differentiation, but adding conditioned medium from activated immune cells
lowered the differentiation potential. The conditioned medium from 12 months
old mice worsened the ability to differentiate into the osteogenic lineage. (B)
Representative images of the calcium deposition stained by Alizarin Red S
comparing 3 and 12 months old MSC under the influence of different
conditioned medium. Twelve months old MSC under the influence of activated
12 months old conditioned medium almost abolished the ability for calcium
deposition. (C) Analysis of the conditioned medium showed an increase of
pro- (IFNγ and TNFα) and anti-inflammatory (IL-10) cytokines from 12 months
old immune cells. N = 6 animals per age, conditioned medium was pooled
and added at a ratio of 1:3 to the osteogenic differentiation medium, assays
were performed in triplicates, mean ± SD, unpaired t-test, *p < 0.05.
FIGURE 8 | In vivo rescue of experience level in the immune system with
mechanical loading. The left tibia of 3 and 12 month old mice underwent daily
(Monday–Friday) in vivo axial compressive cyclic loading for 2 week, thereafter
the bone marrow was flow cytometric analyzed. In 3 month old mice the
mechanical loading of the tibia increased the population of naïve CD8+ T cells
and decreased the effector memory population locally in the bone marrow.
CD4+ Tregs decreased comparably to the effector memory T cells. This more
naïve immune milieu created under mechanical loading is not viable in 12
months old mice. N = 6 animals per age, boxplot distribution with median,
Mann-Whitney U-test, *p < 0.05.
this effect is reduced in aged individuals (36, 44). The question
arose whether this also relates to the immune response involved.
The left tibia of 3 and 12 month old mice underwent daily
(Monday-Friday) in vivo axial compressive cyclic loading for 2
weeks. After 2 weeks, the bone marrow from the loaded and from
the non-loaded contralateral tibia was harvested and analyzed
with flow cytometry. Strikingly, within the loaded tibia of the
young 3 months old mice a more naïve immune phenotype arose
when compared to the contralateral non-loaded bone. In the
bone marrow of the loaded tibia from the 3 months old mice, the
naïve CD8+ T cells increased to 58.7(±3.8)% of all CD8+ T cells
compared to 52.2(±4.1)% in the contralateral non-loaded control
tibia. In addition, the percentage of CD8+ effector/memory T
cells significantly decreased under the influence of loading. This
data suggests that a less inflammatory immune cell composition
supports bone formation in response to loading of young mice
(similar to what we observed in our in vitro experiments). This
more naïve immune cell milieu did not coincide with loading in
the aged, 12 months old mice. CD4+ Tregs, ascribed as potent
anti-inflammatory cells, reacted contrariwise to loading with a
decrease of their proportion within the bone marrow of the
loaded tibia (Figure 8). These findings show that the positive
effect that mechanical loading had in young mice was absent in
the aged animals, and that could indeed be related to differences
in the immune response to the mechanical stimulus.
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FIGURE 9 | Osteogenic differentiation under the influence of immune cell subsets. (A) Naïve T cells compared to CD8+ T cells did not alter the osteogenic
differentiation. Activated CD8+ T cells significantly lowered the calcium deposition. Peripheral blood mononuclear cells (hPBMC) increased the mineralization of the
extracellular matrix compared to the osteogenic medium without immune cells. This is due to a decreased proliferation (B). Conditioned medium from CD8+ T cells
increased proliferation but hindered the osteogenic differentiation of hMSC. (C) Cytokine production of activated CD8+ T cells was strong pro-inflammatory, activated
PBMC mainly produced TNFα but not IFNγ, whereas activated naïve T cells did not produce significant amounts of IFNγ and TNFα. N = 3 immune cell donors, naïve
and CD8+ T cell isolation was performed for each donor, N = 2 hMSC donors, assay was run in triplicates, boxplot distribution with median, mean depicted with a +,
ELISA data shown as mean ± SD, unpaired t-test, *p < 0.05.
To further understand the interdependency of an experienced
immune system and the osteogenic capacity of mesenchymal
stromal cells an in vitro “rescue experiment” was performed by
analyzing specific cellular subsets in view of their effect on the
osteogenic capacity. For this experiment the mouse model where
age and immune experience were distinguishable was changed to
human cells to model the patient situation more closely in vitro.
Naïve and Experienced Human Immune
Cell Subsets Differently Affect Osteogenic
Differentiation and Proliferation
To further elucidate the interrelation between bone structure
and immune experience we selected a more clinically relevant
situation by isolating naïve and experienced immune cells
directly from human peripheral blood. Distinctly different
immune subsets were tested for their influence on the
differentiation capacity of human mesenchymal stromal cells
(MSC). From density gradient isolated human peripheral blood
mononuclear cells (hPBMC) either CD8+ T cells or naïve
T cells were isolated and stimulated in vitro with CD3 and
CD28. Mesenchymal stromal cells were isolated from bone
marrow aspirates from patients undergoing hip surgery with
written consent. The osteogenic differentiation outcome was
calculated per 2000 cells to account for difference between
proliferation and differentiation. Our data clearly showed that
conditioned medium from naïve T cells did not dampen
the osteogenic differentiation ability of MSC, whereas the
conditioned medium from CD8+ T cells almost abolished the
osteogenic differentiation (Figure 9A). Interestingly conditioned
medium from activated CD8+ T cells induced proliferation
in MSC. In contrast the conditioned medium from whole
hPBMC hindered proliferation while supporting osteogenic
differentiation (Figure 9B). Apparently, signaling patterns from
specific immune cell subsets play an important role in
distinguishing whether cell proliferation or differentiation is
supported and activated. Thus, immune cells appear essential in
guiding tissue formation—such as bone formation—and thereby
impact the resulting tissue structure. Quantitative cytokine
detection revealed an inert cytokine pattern in activated naïve
T cells compared to activated CD8+ T cells, which produced a
high concentration of IFNγ and TNFα. PBMC already produced
a faint milieu of TNFα functionally inhibiting the proliferation
of MSCs and therefore promoting the differentiation process as
described within other studies (45) (Figure 9C).
Determining that the immune cell composition influences the
osteogenic potential from mesenchymal stromal cells indicates
that the immune signature will also influence the bone healing
capacity. Thus, the initial observation that aged patients show a
reduced healing capacity (confirmed in a mouse model with an
experienced non-SPF immune cell composition) could be related
to an experienced immune signature. To further investigate this
hypothesis, bone healing was analyzed in a mouse model with a
humanized immune system that was either more naive or already
more experienced.
In vivo: Bone Regeneration Benefits From
a Naïve Immune Milieu
To monitor the behavior of different immune phenotypes
on the in vivo bone regeneration, a humanized peripheral
blood mononuclear cell (hPBMC) mouse model was used: the
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humanized PBMC NOD scid gamma (NSG) mice. NOD.Cg-
Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice lack the ability to activate
their own immune system and some immune subsets are even
completely missing. Human PBMC from different donors were
analyzed toward the immune phenotype and an experience
level for stratification was achieved via the CD8+ TEMRA
level. CD8+ TEMRA cells are known from earlier studies to be
predictive for delayed bone healing as published by Reinke et al.
(42). Donors with a CD8+ TEMRA level above 30% of total
CD8+ T cells were considered as immunologically experienced.
NSG mice received intravenously either naïve or experienced
hPBMCs from stratified donors and consecutively underwent
surgery to introduce a 0.7mm osteotomy gap stabilized with
a unilateral external fixator (MouseExFix, RISystem, Davos,
Switzerland). Healing outcome was assessed 21 days post-surgery
with microCT. Three groups were analyzed: one group did not
receive human immune cells (control), one group received naïve
hPBMCs and one group received experienced hPBMCs. The
transfection efficacy and accumulation of the human immune
cells inside the tissue was verified after 3 and 21 days with
flow cytometry (Figures 10A,B). The callus 21 days post-surgery
showed an increased bone volume fracture (BV/TV) under the
influence of naïve hPBMCs compared to the control as well as
compared to experienced hPBMC. The bone volume fraction for
the group receiving experienced hPBMC did not differ to the
control. Quantifying the bone mineral density (BMD) revealed a
benefit of immune cells on newly formed bone with an increased
mineral density even with experienced immune cells compared
to the control. Remarkably, the group with naïve hPBMC
showed the highest density of mineralization among all groups.
Under the influence of injected hPBMCs newly formed bone
revealed a decrease in trabecular numbers while the thickness
of those structures significantly increased. The naïve hPBMCs
significantly increased the deposition of mineral tissue showing
the positive effect of a young/ naïve immune system on the bone
healing process (Figure 10C). These findings show that bone
regeneration benefits from a more naïve immune system.
DISCUSSION
Changes within the skeletal system upon aging have been
widely acknowledged. This study showed for the first time that
not only the chronological age but also the immunological
age substantially impacts bone mass and microstructure and
should be considered in assessing patient‘s risk factors and
healing potential (42). The immunological age is mostly
determined by changes in the adaptive immune system. With
increasing antigen exposure, the effector and effector memory
pool within the adaptive immunity of an individual increases,
while simultaneously the naïve lymphocyte pool diminishes.
This process of immune-aging is greatly influenced by time
but not per se comparable among individuals, specifically
if they have seen different immune challenges. This is also
mirrored in our data where the immune composition of exposed
mice show an increasing standard deviation in the CD8+
T central and effector memory cell population after 2 years
FIGURE 10 | Fracture healing outcome of humanized PBMC mice. (A)
Representative image of a 21 days old fracture gap. (B) Human immune cells
settled to spleen and bone marrow in significant levels after transfer. (C)
Healing under the influence of either experienced or more naïve peripheral
blood mononuclear cells (hPBMC) showed a beneficial effect of a more naïve
immune phenotype. The bone volume in total volume (BV/TV) was significantly
increased under the influence of more naïve hPBMC compared to the control
without hPBMC and more experienced hPBMC. The bone mineral density
(BMD) and trabecular thickness (Tb.Th) stood to benefit from immune cells.
The more naïve hPBMC further increased the mineral density within the
fracture gap compared to more experienced hPBMC. The number of newly
formed trabecular structures (Tb.N) seemed to decrease under the influence of
more experienced hPBMC. N = 6 animals in the naïve hPBMC group, N = 8
each in control and experienced hPBMC group, boxplot distribution with
median, Mann-Whitney U-test, *p < 0.05.
of environmental exposure (in a still relatively standardized
environment of animal housing). The direction of the immune
aging process is comparable among people, however, the pace
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with which it proceeds differs due to the living environment and
personal habits.
As a first example to illustrate the relevance of the immune
experience, we focused on the common assumption that bone
healing in the elderly is impaired (46), albeit most studies
do not properly document reasons for lack of healing in the
aged population (47). There is a paucity of supportive data
within the scientific literature on the immune experience or
its effect on various biological processes (mainly due to a
lack of proper documentation in preclinical studies). Only
recently have questionnaires such as the ARRIVE guidelines
for preclinical studies included questions related to housing
and husbandry that allow one to determine the immunological
age of an animal. To analyze the effect of the immune
experience on bone homeostasis and healing, immune aging had
to be characterized within a mouse model. By dividing mice
into two groups and keeping those under specific pathogen
free conditions and antigen exposed conditions, respectively,
during aging it became possible to distinguish between skeletal
changes caused by chronological aging vs. changes that were
dependent on the immunological age/state of the animals
(biological aging).
Analyzing immune-aging in mice showed an increase in
memory and effector function with age. The exposure to
antigens in non-SPF housings led to an amplified age-associated
phenotype of the immune system, reflecting the changes seen in
humans (23). One-year-old non-SPF housed mice appeared to be
able to reflect roughly a 40–50 years old human while 2-year-
old non-SPF mice reflected humans of around 50–60 years of
age. Using such approach, a mouse model was established that
allowed the analysis of immune-aging on the bone.
For the analysis of the impact of the immune experience
within the study a model was chosen that enabled the
investigation of mice of the same age but with a differently
developed adaptive immune system due to a difference in
housing (SPF vs. non-SPF). While the animals were held as
similar as possible in order to determine the immune experience
as the source of the changes detected in the bone, additional
influences could have had an impact. The influences of the
changed immune composition could lead to a change in other cell
compartments (e.g., the more pro-inflammatory signaling could
induce higher M1 macrophage percentages), epigenetic changes
could also occur which were not considered within this study.
Also, the microbiota is a potent modulator of the immune system
and vice versa, an influence that would offer future research
opportunities (9, 48, 49). To overcome this possible bias the
humanized PBMC mouse model was applied within this study—
these mice were identical up to the day before osteotomy when
they received the human immune cells and were kept under
identical conditions thereafter for the observation time of 21
days—a time period where the above mentioned changes would
not occur in a meaningful way.
It is well-known that biomechanical properties of bone,
specifically the energy to mechanical failure decreases with
age (50). While our data confirmed the age related changes
in biomechanical properties this is the first study to depict
that some of these changes are intensified by the immune
experience level. This loss in mechanical properties is usually
associated with age-related bone microstructural changes in
both the cortical and trabecular compartments (51–53) So far,
a link between age-related bone loss and adaptive immunity,
specifically the experience of the immune system had not been
investigated (50–54).
On the other hand, cellular senescence occurring in elderly
individuals is a major hallmark of age associated processes
representing various types of stress that cause distinct cellular
alterations, including major changes in gene expression and
metabolism, eventually leading to the development of a
pro-inflammatory secretome (55). In accordance with the
literature the monocyte-macrophage-osteoclast lineage and
the mesenchymal stem cell-osteoblast lineage are affected by
increasing age, which is associated with higher baseline levels
of inflammatory mediators, and therefore a significant reduction
in osteogenic capabilities can be observed (56). This inflamm-
aging affects different signaling pathways, gene expression,
cellular events like proliferation and differentiation, chemotaxis
of precursor cells, expression of growth regulatory factors and
the production of bone structural proteins. All these affected
processes represent the complex orchestration of interdependent
biological events that occur during fracture repair (57).
For the first time, our study clearly illustrates the influence of
the experienced immune phenotype on changes in bone mass,
microstructure, and mechanical properties that go beyond those
attributed to chronological aging. Keeping mice under non-
SPF conditions lead to increased cortical thickness. The stiffness
and maximal force at failure increased with age due to an
increased mineralization density. However, the cortical thickness
changed in conjunction with the altered immune composition.
The experienced immune signature led to an altered and a more
stiff bone structure and a more brittle fracture. Such brittleness
increases the risk of fracture upon low-impact loads or injuries—
a phenomenon frequently seen in aged patients (58). For the
first time, the reduced bone structure and phenotype of an aged
bone found in elderly patients can be seen to be even worsened
by an immune-aged or inflamm-aged setting. The strong link
between immune experience and structural properties makes
an immune diagnostic approach to stratify patients according
to their immune status a relevant perspective, so far widely
ignored in bone treatment and research. Studies from Zhao et al.
using a bioinformatics approach revealed likewise significant
changes in the inflammatory response during fracture healing
upon aging. The inflammatory response was shown to be
enriched in the elderly compared to the younger population. In
addition changes in the Wnt signaling pathway, vascularization-
associated processes, and synaptic-related functions may account
for delayed fracture healing in the elderly (59).
The interdependency of the immune and bone compartment
has been investigated from different perspectives. Concerning the
interplay of osteoclasts and immune cells the pro-inflammatory
cytokines TNFα and IFNγ which were analyzed within this
study as cytokines delaying the healing/ osteogenesis have
been discussed as promoting osteoclastogenesis (60). Bone loss
in postmenopausal osteoporosis has been addressed by anti-
TNFα treatments (61). This indicates the elevated TNFα levels
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could be causative for the postmenopausal bone loss. So far,
the immune experience and the higher TNFα levels going
hand in hand with higher levels of effector memory T cells
has however not yet been considered. That the more pro-
inflammatory state of the experienced immune system with high
numbers of TNFα producing effector memory T cells could be
responsible for reduced bone formation or even bone loss is
also mirrored in previous studies where activated T cells have
been correlated to bone loss in conditions of inflammation and
autoimmune disorders (62, 63), osteoporosis models (64, 65), or
even periodontitis and cancer (66–68).
So far, the age-related alteration in mechano-response was
solely explained by the mechanical signal losing its specificity
to activate osteoblasts or inhibit osteoclasts (69). The here
presented data suggest a reprograming of immunity toward a
more naïve phenotype and thus a potential rescue mode in
young animals. Interestingly, the rescue was only significant in
young individuals but showed similar trends in the older animals,
suggesting the immune system may play a role in the bones
reduced mechano-response with age. The impact of mechanical
loading on adaptive immunity illustrates the immune-structure
relationship, and thus identifies a re-gain in ones naïve immunity
as an additional route that could be exploited therapeutically
in the future. In a clinical study moderate intensity exercise in
adult subjects revealed a decrease of osteoclastogenic cytokines,
showing that biomechanical loading could represent a potential
immune modulator (70).
How is bone healing impacted by the immune status? Upon
a bone fracture, a cascade of sterile inflammatory reactions
are initiated which determine a successful, delayed or failed
bone healing (12, 19, 71–73). Earlier studies have shown that a
prolonged pro-inflammatory response delays the healing process.
Such a prolonged pro-inflammatory cascade could be further
enhanced by the here reported immune-aged or inflamm-
aged status resulting in a more severe delay of healing. The
reported data in the present study demonstrates clearly that
a naïve immune system leads to an effective healing while an
experienced immunity significantly delays bone formation, as
demonstrated by the humanized PBMC mouse models. Again,
patient stratification early on would allow for the identification
of patients at risk of delayed healing due to an immune-
aged status. Preemptive measures could be initiated in these
patients to compensate for their healing deficit. A biomarker
study is currently ongoing to threshold patients by the level
of CD8+ TEMRA cells for a high risk of delayed bone healing
(42). As a potential measure to reprogram immunity toward a
more naïve phenotype, a mechanical limb loading stimulation
such as those experienced in physical exercise was presented.
Although a “rescue” toward a more naïve phenotype could
clearly be found in young (leading also to an enhanced bone
homeostasis) the effect was substantially reduced in a more
aged mouse model. Thus, the effect of mechano-therapeutics
as measures to reprogram the immune system may alone not
be completely sufficient yet. Further in depth understanding of
FIGURE 11 | The immune system impacts bone formation.
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the processes of re-programming the immune compartment,
specifically in inflamm-aged situations seems to be important to
further elucidate the therapeutic potential of mechanical loading
in the senescent skeleton.
CONCLUSION
In conclusion, our data presented here clearly shows for the
first time a distinct link of the immune system to the structural
properties of bone as those involved in bone homeostasis,
regeneration and adaptation. The experience of the immune
system directly impacts bone formation capability and thereby
affects structural properties of trabecular and cortical bone as well
as overall mechanical competence (Figure 11).
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